Post Doctoral Fellow: Carolina Cancer Nanotechnology T32 Training Program
The overarching goal of the CCNTP is to equip outstanding young scientists with the multidisciplinary concepts and skills needed to improve cancer diagnosis and therapy based on concepts, tools and discoveries made in nanoscience and nanotechnology. This is a 24-36-month mentored training program offered at The University of North Carolina Chapel Hill with focus area of research on cancer nanotechnology and is funded by an NIH T32 grant.
This program will include both didactic and experiential training, with an emphasis in one of the following core research focus areas:
- Drug disposition and action
- Drug-induced organ toxicity
- quantitative pharmacology and clinical trial design
Trainees selected for the program may choose to work with any of our 22 faculty members representing 11 departments in three Schools, including physical and material scientists, biomedical engineers, basic biomedical scientists, pharmaceutical scientists, and clinician-scientists, all of whom have demonstrated strong interests and capabilities to work at the interface between nanoscience and cancer.
We combine two broad approaches to the training:
- Active co-mentorship of the trainee’s research project over a year of two years
- Trainee participation in workshops and courses that will broaden their knowledge and conceptual understanding of all areas of cancer nanotechnology.
In each case there will be a physical scientist and a biomedical scientist acting in tandem to guide trainee research. It is expected that this approach will provide unique multi-faceted training experience leading to significant contributions to cancer nanotechnology. The topics of the workshops will reflect many of the major themes of the Alliance for Nanotechnology in Cancer. In addition to activities focused on postdoctoral researchers, the C-CNTP will also embark on a broadly based outreach program to disseminate concepts concerning cancer nanotechnology both within the university community and to the public at large.
Due to NIH restrictions for T32 training, all applicants must be either US Citizens, US permanent residents or US non-citizen nationals.
The typical post-doctoral trainee will have completed highly relevant doctoral training in medical, pharmacy, chemistry, biomedical sciences or related area and was awarded Ph.D., M.D. or M.D./Ph.D.
Qualifications and Expertise
- Full understanding of framing research question, research design and methods, and project implementation;
- Demonstrated proficiency in scientific/manuscript writing, grant writing, poster and oral presentations;
- Preferred candidates will have strong publication record and demonstrated experience in research study design and project implementation.
To Apply - http://unc.peopleadmin.com/postings/80991
The University of North Carolina at Chapel Hill is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to age, color, disability, gender, gender expression, gender identity, genetic information, race, national origin, religion, sex, sexual orientation, or status as a protected veteran.